Monopar Therapeutics
MNPR
MNPR
35 hedge funds and large institutions have $109M invested in Monopar Therapeutics in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4.91% more ownership
Funds ownership: 42.41% → 47.31% (+4.9%)
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.52M | |
| 2 | +$2.26M | |
| 3 | +$2.2M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$946K |
| 5 |
Goldman Sachs
New York
|
+$673K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$86.5K | |
| 3 | -$70.5K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$46.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$14.3K |
